MGfC Clinical Experts Lead International Myhre Syndrome Conference
Tapping expertise from Mass General for Children, the Myhre Syndrome Foundation launched its inaugural conference on July 10-11, 2021.
Dr. Mark Lindsay is a cardiologist specializing in Genetic Aortic Disease, Massachusetts General Hospital and Massachusetts General Hospital for Children Assistant Professor of Medicine, Harvard Medical School.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Heart Center
55 Fruit St.
Boston, MA 02114
Phone: 866-644-8910
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
My research interest is the clinical expression and molecular etiology of human arterial disease. In my research I utilize human and murine genetics as well as animal modeling to investigate the etiology and pathologic progression of inherited and sporadic arterial diseases. Through this work I hope to discover better diagnostics and novel therapies for patients with these serious conditions.
My research biography is available at: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/51274044/?sort=date&direction=descending
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Tapping expertise from Mass General for Children, the Myhre Syndrome Foundation launched its inaugural conference on July 10-11, 2021.
Tapping expertise from Mass General for Children (MGfC), the Myhre Syndrome Foundation (MSF) launched its inaugural conference on July 10 - 11, 2021.
At 16, Anna Young was diagnosed with Myhre Syndrome, a very rare genetic condition. Since coming to the Myhre Syndrome Clinic at MGfC, she has found her place in the world and learned the skills to thrive as a young adult.
Findings from the research breakthrough allow clinicians to commence therapy for a young patient targeting the real source of the disease.
Mutations in genes that direct the production of fibrillar collagens, essential components of blood vessel walls, appear to predispose individuals to SCAD.
The results could also lead to new strategies to prevent and treat enlarged aortas.